UnitedHealth acquired or created 250 subsidiaries in 2024 as it pursues an ambitious vertical integration strategy.

We recently published a list of 10 Most Undervalued High Quality Stocks to Buy According to Analysts. In this article, we are ...

Vertex Pharmaceuticals (NASDAQ:VRTX) ended a four-day winning streak on Thursday after UnitedHealth (NYSE:UNH) placed its new ...

The civil fraud case against UnitedHealth Group, the nation’s largest Medicare Advantage insurer, was filed in 2011.

A court-appointed special master has found that U.S. authorities do not have evidence to support their billion-dollar fraud ...

UnitedHealth's revenue faces risks from potential Medicare and Medicaid budget cuts. See here to know why I have revised my ...

The case began with a whistleblower who said UnitedHealth bilked billions of dollars through the Medicare Advantage program.

The Boston-based company's new medication, called Journavx, is being placed on a tier that means it might be costlier than ...

A court-appointed special master says the Justice Department hasn’t developed “any evidence” for key claims. Her ...

Investment analysts at Zacks Research increased their Q1 2025 earnings estimates for shares of UnitedHealth Group in a report released on Thursday, March 6th. Zacks Research analyst D. Chatterjee now ...

The Justice Department lacks evidence to support claims the company withheld Medicare Advantage funds, a legal expert ...

Vertex's Journavx, a new non-opioid pain drug, lands Tier 3 on Optum Rx formularies. Vertex reports $2.91 billion Q4 sales.